Cunha Anita, Póvoa Ana Margarida
Faculty of Medicine, University of Porto.
Department of Gynecology, Unit of Reproductive Medicine, São João University Hospital Centre.
Porto Biomed J. 2021 Jan 26;6(1):e116. doi: 10.1097/j.pbj.0000000000000116. eCollection 2021 Jan-Feb.
Polycystic ovary syndrome is the most common endocrine disorder in women and a major cause of anovulatory infertility. Various medical options are used, alone or in combination, to treat subfertility associated with polycystic ovary syndrome. This narrative review was conducted to provide an update and summarize the available evidence on the management of polycystic ovary syndrome related infertility. A wide literature search was performed and preferably randomized controlled trials and systematic reviews were included. Management is often centered on lifestyle changes. Pharmacological ovulation induction is the next step, with recommended use of letrozole, clomiphene citrate or gonadotropins. When it fails, assisted reproductive technologies or laparoscopic ovarian drilling are frequently advised. Combination treatment with metformin is often recommended. More recent alternative and adjunctive treatments have been suggested, like inositol, vitamin D, bariatric surgery and acupuncture, but further research is needed for recommendation.
多囊卵巢综合征是女性最常见的内分泌疾病,也是无排卵性不孕的主要原因。人们单独或联合使用各种医学方法来治疗与多囊卵巢综合征相关的生育力低下问题。进行本叙述性综述的目的是提供最新信息,并总结关于多囊卵巢综合征相关不孕症管理的现有证据。我们进行了广泛的文献检索,优先纳入随机对照试验和系统评价。管理通常以生活方式改变为中心。药物促排卵是下一步措施,推荐使用来曲唑、枸橼酸氯米芬或促性腺激素。当药物促排卵失败时,常建议采用辅助生殖技术或腹腔镜卵巢打孔术。通常推荐联合使用二甲双胍进行治疗。最近有人提出了一些替代和辅助治疗方法,如肌醇、维生素D、减肥手术和针灸,但还需要进一步研究才能给出推荐建议。